HUTCHMED (China) Limited
HCM
$17.27
-$0.51-2.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 230.78M | 230.78M | 84.32M | 84.32M | 239.41M |
| Total Other Revenue | -68.52M | -68.52M | 68.52M | 68.52M | -86.85M |
| Total Revenue | 162.26M | 162.26M | 152.84M | 152.84M | 152.56M |
| Cost of Revenue | 190.43M | 190.43M | 90.07M | 90.07M | 239.06M |
| Gross Profit | -28.17M | -28.17M | 62.77M | 62.77M | -86.50M |
| SG&A Expenses | 27.55M | 27.55M | 28.91M | 28.91M | 32.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 170.35M | 170.35M | 166.60M | 166.60M | 199.20M |
| Operating Income | -8.09M | -8.09M | -13.76M | -13.76M | -46.64M |
| Income Before Tax | 8.16M | 8.16M | 14.53M | 14.53M | -33.30M |
| Income Tax Expenses | 2.15M | 2.15M | 1.44M | 1.44M | 889.50K |
| Earnings from Continuing Operations | 6.00M | 6.00M | 13.08M | 13.08M | -34.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -38.50K | -38.50K | -182.00K | -182.00K | 301.50K |
| Net Income | 5.96M | 5.96M | 12.90M | 12.90M | -33.89M |
| EBIT | -8.09M | -8.09M | -13.76M | -13.76M | -46.64M |
| EBITDA | -5.05M | -5.05M | -10.63M | -10.63M | -44.44M |
| EPS Basic | 0.01 | 0.01 | 0.02 | 0.02 | -0.04 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | -0.02 |
| EPS Diluted | 0.01 | 0.01 | 0.02 | 0.02 | -0.04 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | -0.02 |
| Average Basic Shares Outstanding | 854.67M | 854.67M | 856.03M | 856.03M | 852.38M |
| Average Diluted Shares Outstanding | 873.12M | 873.12M | 872.53M | 872.53M | 852.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |